← Back to patent-cliff list
CAS 1620056-83-8
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
Chain position details for this CAS are not yet recorded.
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications |
|---|---|---|---|---|---|
| Unibest Taizhou GMP-like Site | 2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid Pharmaceutical Intermediates | 询价 | 询价 | 询价 | — |
Listed key intermediates
| Product / CAS | Purity / impurities | Capacity | Qualifications | Packing / cold chain | MOQ / price band | Action |
|---|---|---|---|---|---|---|
Lenacapavir INT-3｜环丙烷并环戊烷吡唑乙酸 1620056-83-8 | ≥99.0% | 700 kg/年 | US DMF冷链 | 1 kg 铝瓶 · 冷链 | 0.5 kg · US$ 5,800-8,200 / kg |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.